Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells.
about
Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II studyUpregulated human telomerase reverse transcriptase (hTERT) expression is associated with spinal chordoma growth, invasion and poor prognosis.Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantationGene therapy and immunotherapy of prostate cancer: adenoviral-based strategies.The rationale for prophylactic cancer vaccines and need for a paradigm shift.Telomerase-based immunotherapy of cancer.A review of vaccine clinical trials for non-small cell lung cancer.Telomerase immunity from bench to bedside: round one.Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response.Prospects and challenges of building a cancer vaccine targeting telomeraseIn vivo expansion of the residual tumor antigen-specific CD8+ T lymphocytes that survive negative selection in simian virus 40 T-antigen-transgenic mice.Clinical implications of antitelomeric drugs with respect to the nontelomeric functions of telomerase in cancerThe functioning antigens: beyond just as the immunological targets.Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer.Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancer.Telomerase and the endocrine system.Is telomerase a viable target in cancer?Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine.Retention of immunogenicity produced by mucin 1 peptides with glycosylation site substitutions.Identification of an immunogenic CD8+ T-cell epitope derived from gamma-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemia.Tumor-associated antigens for specific immunotherapy of prostate cancerNeoantigen prediction and the need for validation.Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001.
P2860
Q24652592-12E7BEA7-6784-41B6-9351-6726ADE567ACQ33276030-80EB90E0-31B7-4B3F-9F48-76F5C515BE3EQ35588845-BA858D54-E215-428C-8E95-D5FA3AAFFD56Q36258513-71D12551-5FCB-417D-8DE5-8A7598DC048CQ36423899-9F052E3E-CCBA-4602-9DF7-221C34C0A425Q36600251-463E45A8-A706-423C-AF1A-3F1861A8DE3CQ36675454-C2B002DD-9B19-45F2-9FA0-8B29B77DBA14Q36745749-ACB796A0-E656-4469-A853-2E99836C7EE6Q36821063-74E1E9C6-5A12-47BC-AB31-FD68E766AC91Q36918394-0ACE8977-8564-4CE7-A1AA-99228382B918Q36959354-87DE080F-4ACE-4FC6-9F78-54340A9CE00EQ37146556-3E49A690-9A42-4737-B9A3-0DDC2A6CF498Q37483795-70EF688C-2F86-4A73-8887-CBB0B7FCF43AQ37741161-8A7434B5-4FB9-49B5-B6D9-841B32B97929Q37785948-0A6E11FB-6548-4EAC-A377-7C22BFB61682Q37859251-2B5BC586-4819-4757-AEA0-CC1306C8D622Q37908470-AB171471-A7F3-4FCD-9E40-2F88D01025F1Q38077405-A5CD8952-7E1B-4971-B9FA-74F34BB9A580Q39703930-0C63484A-D349-445F-893B-84E37A2EAF1BQ41809404-0E8174AD-2AA1-4B4E-9832-D226EF9D6938Q41977894-72135B9F-6CB3-442F-A0E8-D6C37C022B0CQ46969749-268E5ADF-52C3-4ED3-A2FF-E4655A9C989AQ54566447-FCAFCDB5-05F0-4133-9F7F-F99825692AA4
P2860
Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Identification of a human telo ...... mediates lysis of tumor cells.
@ast
Identification of a human telo ...... mediates lysis of tumor cells.
@en
Identification of a human telo ...... mediates lysis of tumor cells.
@nl
type
label
Identification of a human telo ...... mediates lysis of tumor cells.
@ast
Identification of a human telo ...... mediates lysis of tumor cells.
@en
Identification of a human telo ...... mediates lysis of tumor cells.
@nl
prefLabel
Identification of a human telo ...... mediates lysis of tumor cells.
@ast
Identification of a human telo ...... mediates lysis of tumor cells.
@en
Identification of a human telo ...... mediates lysis of tumor cells.
@nl
P2093
P2860
P356
P1476
Identification of a human telo ...... mediates lysis of tumor cells
@en
P2093
Francisco Garcia-Pons
Huseyin Firat
Joseph D Schmidt
Maurizio Zanetti
Pierre Langlade-Demoyen
P2860
P304
12275-12280
P356
10.1073/PNAS.182418399
P407
P577
2002-09-06T00:00:00Z